Lexpert has included 21 McCarthy Tétrault lawyers in its inaugural Special Edition: Insolvency and Restructuring. Those featured in the publication are current Lexpert-ranked lawyers already recognized for their expertise in corporate tax, banking… Read More
KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announced that it has entered into a definitive agreement for the purchase… Read More
Publication of Eupraxia’s Phase 2b data in Lancet Rheumatology, a distinguished and respected journal, raises the profile of EP-104IAR. As outlined in Lancet Rheumatology, Eupraxia’s EP-104IAR imparts clinically significant and durable pain relief,… Read More
BOSTON, MA & VANCOUVER, BC – Alpha-9 Oncology (“Alpha-9” or the “Company”), a clinical stage company developing radiopharmaceuticals for the treatment of cancer patients worldwide, announced the appointment of industry veterans Jean-Jacques Bienaimé… Read More
Despite global annual inflation expected to decrease, medical plan costs on the rise DUBLIN, IRE – Aon plc (NYSE: AON), a leading global professional services firm, forecasts medical plan costs across the… Read More
